Press Releases

New Analysis by Tufts’ NEWDIGS Shows that Durable Cell and Gene Therapies Have Substantially Higher Clinical Success Rates than Other Treatments

October 11, 2023

Carlsbad, CA

The Alliance for Regenerative Medicine Announces Election of 2024 Board of Directors

October 10, 2023

Carlsbad, CA

Alliance for Regenerative Medicine Promotes Michael Lehmicke to Senior Vice President, Science & Industry Affairs

July 19, 2023

Washington, DC

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the promotion of Michael Lehmicke to Senior Vice President, Science & Industry Affairs, effective immediately.

Proposed joint clinical assessment methodology would have rejected nearly 90% of the ATMPs currently authorized in the EU

June 20, 2023

BRUSSELS

Without changes recognizing the unique characteristics of ATMPs, the EU’s new Joint Clinical Assessment will fail to deliver the next generation of transformative therapies to rare disease patients, according to the Alliance for Regenerative Medicine, EveryLife Foundation for Rare Diseases, and Rare Diseases International.